Abhishek M S, Nagraj T R
Department of Anaesthesia, Sri Siddhartha Medical College, Tumkur, Karnataka, India.
Anesth Essays Res. 2020 Apr-Jun;14(2):208-212. doi: 10.4103/aer.AER_70_20. Epub 2020 Oct 12.
In recent years, several adjuvants have been used to prolong the duration of the subarachnoid block. These adjuvants have either been used via intrathecal route or intravenous (i.v.) route. Dexmedetomidine and clonidine have been used as adjuvants to local anesthetic drugs by intrathecal, epidural, caudal, and i.v. routes and for peripheral nerve blocks. In this study, we endeavored at finding the efficacy of dexmedetomidine and clonidine in improving the analgesia quality and duration of the subarachnoid block.
A prospective, double-blind, randomized control trial comprising 70 subjects posted for elective lower limb surgeries.
Seventy patients were selected at random and were allocated to two groups (Group C and Group D) of 35 each. In Group C, the patients received isobaric ropivacaine with clonidine 1.0 μg.kg intravenously. In Group D, the patients received isobaric ropivacaine with dexmedetomidine 0.5 μg.kg intravenously. Perioperatively, heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, and oxygen saturation were recorded and documented every 5 min till the end of surgery. Time of onset, level of sensory blockade, and duration of sensory blockade were recorded. Motor block was assessed using modified Bromage scale. Data validation and analysis were carried out by SPSS version 16. A < 0.05 was considered statistically significant.
Time of onset of sensory block in Dexmedetomidine group and Clonidine group was 2.70 ± 1.25 minutes and 3.50 ± 1.23 minutes respectively ( = 0.021). Time of onset of motor block in Dexmedetomidine group and Clonidine group was 3.55 ± 1.60 minutes and 4.30 ± 1.45 minutes respectively ( = 0.034). Time for 2 segment regressions of sensory block in Dexmedetomidine group and Clonidine group was 140.30 ± 12.32 minutes and 125.65±14.33minutes respectively ( = 0.047). Time of regressions of motor blockade to Bromage Scale 1 in Dexmedetomidine group and Clonidine group was 148.65 ± 15.23 minutes and 129.70 ± 19.35 minutes respectively ( = 0.032).
The use of i.v. dexmedetomidine perioperatively prolongs the duration of sensory and motor block significantly when compared to i.v. clonidine.
近年来,几种佐剂已被用于延长蛛网膜下腔阻滞的持续时间。这些佐剂通过鞘内途径或静脉途径使用。右美托咪定和可乐定已通过鞘内、硬膜外、骶管和静脉途径用作局部麻醉药物的佐剂,并用于外周神经阻滞。在本研究中,我们致力于探究右美托咪定和可乐定在改善蛛网膜下腔阻滞镇痛质量和持续时间方面的疗效。
一项前瞻性、双盲、随机对照试验,包括70例择期下肢手术患者。
随机选择70例患者,分为两组(C组和D组),每组35例。C组患者静脉注射等比重罗哌卡因加1.0μg/kg可乐定。D组患者静脉注射等比重罗哌卡因加0.5μg/kg右美托咪定。围手术期,每5分钟记录并记录心率、收缩压、舒张压、平均动脉压和氧饱和度,直至手术结束。记录感觉阻滞的起效时间、感觉阻滞平面和感觉阻滞持续时间。使用改良的布罗玛格量表评估运动阻滞。数据验证和分析采用SPSS 16版进行。P<0.05被认为具有统计学意义。
右美托咪定组和可乐定组感觉阻滞的起效时间分别为2.70±1.25分钟和3.50±1.23分钟(P = 0.021)。右美托咪定组和可乐定组运动阻滞的起效时间分别为3.55±1.60分钟和4.30±1.45分钟(P = 0.034)。右美托咪定组和可乐定组感觉阻滞2个节段消退的时间分别为140.30±12.32分钟和125.65±14.33分钟(P = 0.047)。右美托咪定组和可乐定组运动阻滞消退至布罗玛格量表1级的时间分别为148.65±15.23分钟和129.70±19.35分钟(P = 0.032)。
与静脉注射可乐定相比,围手术期静脉注射右美托咪定可显著延长感觉和运动阻滞的持续时间。